awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37362747-0C24924A-58CE-4A53-9662-B0ADBD6B4AFE
Q37362747-0C24924A-58CE-4A53-9662-B0ADBD6B4AFE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37362747-0C24924A-58CE-4A53-9662-B0ADBD6B4AFE
TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
P2860
Q37362747-0C24924A-58CE-4A53-9662-B0ADBD6B4AFE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37362747-0C24924A-58CE-4A53-9662-B0ADBD6B4AFE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ec3d0969fb000c55589b7fdf04293155df68ba65
P2860
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer